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Abstract 
 
Xenogeneic bone graft materials are an alternative to autologous bone grafting. Among such implants, 
coralline-derived bone grafts substitutes have a long track record as safe, biocompatible and 
osteoconductive graft materials. In this review, we present the available literature surrounding their use 
with special focus on the commercially available graft materials. Corals thanks to their chemical and 
structural characteristics similar to those of the human cancellous bone have shown great potential  
but clinical data presented to date is ambiguous with both positive and negative outcomes reported. 
Correct formulation and design of the graft to ensure adequate osteo-activity and resorption appears 
intrinsic to a successful outcome.  
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Introduction 
Bone grafting is the most common transplant procedure performed today. It is estimated that 
approximately 450,000 bone transplantation procedures are performed annually in the USA and 2.2 
million worldwide.1 Autologous bone grafting has all the properties of the ideal graft material, being an 
osteoinductive and osteoconductive scaffold with no immunogenicity and containing significant 
numbers of osteoprogenitor cells.2,3 However, its use has several drawbacks including limited 
availability, variable graft quality, increased operative time and donor site morbidity.4 To overcome the 
increasing need for bone graft materials, research has focused on the development of novel bone graft 
substitutes.5,6 A large number of substitutes have been developed and a significant number are 
commercially available for clinical use. 
Bone graft biomaterials derived from mineralizing marine organisms have been vividly 
investigated over the last 50 years. Several marine species produce mineralized structures within their 
anatomy that resembles the human bone.7 Examples of such species include sponges (Porifera), red 
algae (Rhadophyta), corals (Cnidarians) and a range of other organisms like snails (Mollusca), starfish 
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(Echinodermata) etc.7 Among such marine derived biomaterials, corals are one of the most studied in 
the field of bone tissue engineering. The aim of the herein manuscript is to present the available 
literature on coral bone substitutes. 
 
Corals as graft material  
 
Corals are marine invertebrates belonging in the class Anthozoa of phylum Cnidaria. They are 
approximately 7 thousand species and can be classified as soft corals (without an inorganic structure) 
and hard corals or stony corals. The hard corals typically live in compact colonies of many identical 
individual polyps. The polyps reside in a centripetal exoskeleton. The outer layer of the corals is 
inhabited by calcicoblasts, which like the osteoblasts they produce a hard outer skeleton composed 
of calcium carbonate which, strengthens and protect the organism.    
Studies on the coralline structure revealed significant similarities to that of cancellous bone.8 
The coralline material is characterized by a uniform network of interconnected channels and pores 
similar to those in osteon-evacuated bone grafts.8,9 When implanted in-vivo was found to be 
biocompatible. It allowed vascular ingrowth and inhabitation of cell lineages found in bone. The new 
bone formation occurred without an intervening endochondral phase.8 Resorption of the corals is carried 
out by osteoclastic activity and the actions of the carbonic anhydrase enzyme.10 Resorption is linked to 
bone apposition and can be influenced by the systemic administration of acetazolamide, a diuretic 
inhibiting carbonic anhydrase.10,11 Among the different coral species, significant structural differences 
exist. This could have direct implications to their bone forming capacity. It has been previously 
proposed that the larger the porosity volume, the greater was the coral resorption as well as the new 
bone apposition.12 Three main species have been investigated as bone graft substitutes: Acropora sp., 
Goniopora sp., and Porites sp. Porites sp. have a homogeneous structure and consistent pore size while 
Goniopora sp. have a bimodal pore size and a strongly disordered structure.12,13 Acropora have oriented 
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pores, irregular pore size and the largest permeability compared to Goniopora and Porites sp.13 Their 
transverse section however, was closed and the useful size was limited because of its habitat type.13  
Porites had the smallest pore size and had the lowest permeability. Other coral genera have been 
previously investigated but with very limited use.14,15,16 Among them, Dichocoenia stokes were found 
to trigger a foreign-body reaction when implanted in rabbits.14 These corals were also found to have 
slow resorption rates.15 Facites and Lobophyllia and Pocillopora have a skeletal structure similar to the 
diaphysis of compact bone with a dense and compact outer wall (theca) surrounded by a thin inner septa 
(closed porosity).16,17  Other coral genera exist like  the Montipora, Fungia, Polyphyllia, Acanthastrea, 
and Turbinaria but our current available evidence on these corals is rather poor or non-existent. 
In the early 70s, observations suggesting that porous structures have improved bone integration 
sparkled a race towards the ideal bone graft substitute.18 The foundations of stony corals as biomaterials 
have been set a few years later by the work of White et al.19 White et al. proposed the replamineform 
technique (replicated life forms) which could be used to duplicate the coral carbonate microstructure 
and convert it to ceramic, metal, or polymer materials. Utilizing this technique the unique coral pore 
structures composed of the brittle calcium carbonate could be preserved and copied to produce an 
alternative material with the same structure but converted to hydroxyapatite. In addition to the converted 
form, corals have been used in their natural form i.e. as calcium carbonate. The bone formation of both 
calcium carbonate and hydroxyapatite occurred initially on surface of the pore regions and progressed 
toward the center of the pore and was linked to graft resoption.20 At present there are two commercially 
available corals: the Biocoral ® composed of corals on their natural form and Pro Osteon composed 
of coralline material converted to hydroxyapatite. 
Experimental Studies 
 
I. In-vitro studies 
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The vast majority of the available in-vitro studies have analysed the biocompatibility between 
the corals and the osteoprogenitor cells. Scaffolds derived from corals should be able to support the 
attachment, proliferation and differentiation of Mesenchymal Stem Cells (MSCs) and osteoblasts.21 The 
available studies showed that the corals are not cytotoxic and promote cell growth.22 When cells were 
seeded on coral granules revealed good attachment, spread, and proliferation on the material 
surface.23 Comparing cryopreserved bone allograft, coralline hydroxyapatite and demineralized freeze-
dried dentin revealed that coralline hydroxyapatite was the most potent promoter of the long term 
cellular attachment.24 In a similar study including commercially available graft products, Doherty et al. 
compared the levels of cellular attachment of rat bone, Surgibone® , Ostilit® , Biocoral® and Tisseel®.25 
The results showed that rat bone and Tisseel® (fibrin glue) had the greatest cell affinity followed by 
Biocoral® and Surgibone®, while Ostilit® did not facilitate cellular attachment. 
Following osteogenic induction, mineralized matrix and alkaline phosphatase activity was noted 
within the coral particles.23,26 DNA content, ALP activity, Ca content were significantly higher in 
osteoblasts seeded in coral scaffold in comparison to other materials.26  Mineralized nodules formation 
(both in area and number) was more predominant on the coral surface than in glass disk.26 Gene 
expression analysis of osteoblasts loaded on coral Porites sp. scaffolds showed an increased expression 
of the RUNX2, osteopontin, alkaline phosphatase and osteocalcin genes. The authors concluded 
that coral is a favourable carrier for osteogenetically competent cells to attach and remain viable.27 In 
another study significantly higher levels of osteogenic differentiation markers, namely alkaline 
phosphatase (ALP), Osteocalcin (OC) levels, and Osteonectin and Runx2, Integrin gene expression 
were detected in the cultures on corals (Porites sp) in comparison to bone.28 
 A number of authors have tried to expand corals properties with the addition of an osteoinductive 
element. Coral particles are capable to absorb and subsequent elute transforming growth factor beta 1 
(TGF-beta1) in vitro.29,30,31 TGF-beta1 release was also found to vary with particle size, higher release 
being obtained with the smaller particles.29 In a study by Zhang et al. a coral/chitosan composite was 
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combined with a plasmid encoding platelet-derived growth factor B (PDGF-B) gene. The resulted 
scaffold found to upregulate the proliferation and the PDGF-B expression of the seeded cells.30 
Combinations of platelet-rich plasma (PRP), marrow stromal cells (MSCs) and porous coral have 
shown to exert a higher osteogenic effect.31 
 
II. Animal Studies 
 
The available evidence based on experimental animal studies which explore the potential of 
coralline grafts to support bone healing can be subdivided in three distinct methodologies; studies where 
the coralline grafts have been implanted in ectopic places, studies where coralline material implanted 
on bone in cases of fracture healing or bony defects site and finally composite coralline grafts preloaded 
with growth factors in applications including bone defects spinal fusion.  
Ectopically implanted coral material seem to be biocompatible but inner without inducing an 
osteogenic response.32 Once an osteoinducing signal is added either in the form of osteogenic cells or 
growth factors, bone formation is initiated.32,33,34 The structural characteristics and the degree of bone 
formation was found to be linked to the resorption of the calcium carbonate corals.32,35 Such approach 
can result in the construction of material of predesigned shape with structure similar to the native 
bone.33,36 This strategy can be utilized to fabricate pre-vascularized tissue engineered bone grafts.37 
Such grafts can have a predetermined shape, organized internal vascular network with a vascular pedicle 
attached to the graft.37 Furthermore, comparative studies have highlighted that new bone formation was 
higher in the Porites coral and Acropora coral than in either the beta-tricalcium phosphate or the banked 
bone constructs.32 Analyzing further the way that bone formation occurs within the corals it is of interest 
to mention the work of Ripamonti et al. group.38,39 A partially converted corral, composed of 7% 
hydroxyapatite and calcium carbonate was preloaded with verapamil (calcium channel blocker) or 
bipsosphonate zoledronate (osteoclast inhibitor) and implanted intramuscularly in baboons.38 The 
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results showed that the inhibition of movement of calcium and osteoclastic functions strongly inhibited 
the induction of bone formation. BMP-2 downregulation with the up-regulation of Noggin genes was 
noted indicating that the induction of bone formation by coral-derived macroporous constructs is via 
the BMPs pathway. The same group, has also shown that if the same coral material is loaded with hTGF-
ȕ ERWK WKH DGMDFHQW PXVFOH DQG WKH PDFURSRURXV ELRUHDFWRU VKRZ XSUHJXODWLRQ RI %03-2 up-
regulation.39 This finding correlates with the observation of bone formation occurring at the periphery 
of the graft but also could be the result of the recruiting of osteoprogenitor cells from the adjacent soft 
tissues. 
Coralline graft material implanted adjacent to bone in the treatment of bone defects has been 
analysed by a number of authors.40,41,42 Intra-bony defects in dogs treated with either coralline calcium 
carbonate graft (Biocoral®) or autologous bone showed no difference in terms of healing.41 In 
osteochondral defects, application of Biocoral ® resulted in bone ingrowth associated with graft 
resorption and noticeably enhance the overall healing of the defect. Intra-articular defects filled with 
coralline hydroxyapatite had no adverse effects to the joint environment in comparison to other graft 
materials that can generate inflammation of the synovium and damage the cartilage when their particles 
are released in the joint.40 The coralline hydroxyapatite graft was found to be surrounded by new bone 
but there was minimal resorption of the graft. In another study, the bone ingrowth of a coralline 
hydroxyapatite material (Interpore 500) at 1 years post-implantation was found to be limited to 66.5 % 
of the surface of the graft raising concerns over its overall resorption.43 Poor results have been also 
reported when hydroxyapatite granules (Pro Osteon 200) were used around porous coated metal 
implants.7 The results showed that the grafted implants were largely encapsulated in fibrous tissue and 
the addition of concentrated autologous bone marrow did not change the outcome. 
Composite grafts composed of coralline material and growth factors or cells has been utilized 
by a number of authors.44-52 Combinations of coral graft, BMPs and osteoprogenitor cells have shown 
potent bone healing potential which was comparable to the autologous bone grafting.44,45,46,48,49 The 
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cellular component of the composite graft originate in the vast majority from bone marrow. However, 
osteogenically induced adipose tissue stem cells have been utilized with favorable results.45 Transfected 
cellular lines with vascular endothelial growth factor resulted in enhanced vascularization and 
resorption of the coralline graft and a higher osteogenic response.52 In single-level posterolateral lumbar 
arthrodesis performed in 48 adult New Zealand White rabbits, the combination of BMPs and coralline 
hydroxyapatite resulted in 100% fusion rates.53 This was in contrast to the groups receiving coralline 
hydroxyapatite with bone marrow (0% union rates) and the coralline hydroxyapatite with autogenous 
iliac crest bone (50% union rates). The authors concluded that when coralline grafts were combined 
with autogenous iliac crest bone graft served as a graft extender yielding results comparable to those 
obtained with autograft alone.53 In addition to BMPs other molecules have been investigated. In a 
comparative study of Insulin growth factor-1 (IGF-1) and BMP-2, IGF-1 was more potent inducer of 
bone regeneration when loaded on a coralline hydroxyapatite scaffold for the treatment of proximal 
tibial defects.50 Platelet rich plasma was found to significantly upregulate the bone healing process when 
loaded on corals for the treatment of radial diaphyseal critical size defects.47,51 Cylindrical calcium 
carbonate implants loaded with bovine-derived bone proteins were used in the treatment of a canine 
segmental bone defects.54 The results revealed healing of the defect with total resorption of the coralline 
material at 12 weeks following implantation. It also highlighted the absence of union in the control 
group representing the coralline implants alone. Contradictory results though have been reported. In 
segmental tibial defects in sheep, composite grafts composed of calcium carbonate (Biocoral ), BMP 
and IV collagen resulted in a large amount of callus compared to the coral alone with no significant 
difference in the mechanical strength of the resulted bone.55 This study however highlighted a 
statistically significant increase in the detectable ant-BMP antibody, suggesting an underlying 
immunogenic reaction.  
 
Commercially available Corals 
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i Pro Osteo TM  (former Interpore, Biomet, USA) 
 
 
  Pro Osteon is a graft substitute derived from Goniopora or Porites corals. It is fabricated 
utilizing a replamineform process, which involves the conversion of the calcium carbonate exoskeleton 
to a crystalline hydroxyapatite replica. In this process all the organic material of the corals are extracted 
and the microarchitecture is preserved. The result is a graft material with longitudinal pores of 500-600 
microns and interconnecting pores of 220-260 microns in diameter.56 Pro Osteon comes in two 
varieties; Pro Osteon 500  and 200 with the number following the trade name designating the nominal 
pore diameter.  
 More recently, a resorbable version of this graft has been developed. This new product utilizes the 
replamineform process producing a composite of calcium phosphate and calcium carbonate. This 
composite graft has an outer layer of calcium phosphate while the core of the material remains as 
calcium carbonate. Therefore, due to the fact that calcium carbonate can be resorbed faster than calcium 
phosphate, the graft can facilitate the remodeling allowing more effective bone ingrowth within the 
graft material.      
  There have been a number of clinical studies analyzing the effectives of Pro Osteon in a range 
of clinical applications [Table 1].56-73 The majority of the studies involve cases of periodontal and 
maxillofacial defects. These studies revealed the presence of new bone formation, integration of the 
implant with reduction in the defect size.57,58,59,60 A poor resorption of the implant was highlighted in 
some studies.61  
In 10 cases of hindfoot arthrodesis the application of Pro Osteon 500 had satisfactory results 
with one case of nonunion.62 The group reported on the poor resorption of the graft and the difficulties 
they faced to contain the graft material and the asymptomatic extrusion of the graft in all the cases. In 
tibial plateau fractures, no difference was noted between the cases treated with Pro Osteon and those 
with autologous bone graft.63  
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In cases of spinal fusion the results were mixed. In one study of idiopathic scoliosis surgery the 
utilization of coralline hydroxyapatite resulted in fusion in all 27 patients.64 The authors reported on the 
µPDUELOL]HG¶ DSSHDUDQFH RI WKH JUDIWV ,Q DQRWKHU VWXG\ RI  FDVHV RI SRVWHURODWHUDO OXPEDU IXVLRQ
augmented with Pro Osteon 500, a union rate of 92.5% was noted.65 In 13 cases of revision following 
spinal surgery where hydroxyapatite was used, foreign-body like giant cells and the development of 
inflammatory granulation tissue around graft was noted.66 In a study of 60 cases of instrumented 
posterolateral lumbar and lumbosacral fusion using either Pro Osteon 500 R or iliac bone graft or 
both, there were no cases of non-union with complete resorption 1 year postoperatively.67 It was also 
highlighted that the incorporation of coralline hydroxyapatite mixed with local bone and bone marrow 
needs adequate bleeding bone surface. Pro Osteon 500R use was found to be inappropriate for 
intertransverse posterolateral fusion, because the host bone in this area is little. However, the use of 
hydroxyapatite over the decorticated laminae that represents a wide host area was followed by solid 
dorsal fusion within the expected time.67 
 
  
ii Biocoral ® (Inoteb, Saint-Gonnery, France) 
 
 
  Biocoral ® is a coral-derived bone graft in its natural pure form composed of 99% calcium 
carbonate and the remaining ~1% includes simple amino acids.11 It undergoes minimal processing to 
remove potential contaminants and preserves the original morphology and chemistry. Acropora genera 
obtained from the French part of the Great Barrier Reef in New Caledonia is used for this product.67      
Clinical studies utilizing Biocoral ® have shown mixed results.74-83 Early studies have utilized 
Biocoral ® in the treatment of bony maxillofacial defects. Of interest is the study of Roux et al. presented 
the outcome of this product in 183 patients.74 They reported that the coral block moved or was partly 
resorbed and split into pieces after 7 to 36 months in 20% of cases.  At 1 year 40 to 50% resorption rate 
was noted and the overall infection rate was 4%. In another study when Biocoral® was implanted in the 
anterior maxilla a high revision rate was observed (83% revision rate) in contrast to posterior maxilla 
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and mandible (6% revision rate). 75 In cervical fusion a poor fusion rate of 45 % and 60% has been 
reported in two studies of 48 and 40 patients.76,77 In scaphoid fractures, the utilization of a composite 
graft composed of Biocoral®, BMP and collagen resulted in a high failure rate of 80%.78 The use of the 
same implant however, in 4 diaphyseal and one olecranon ulnar non-union resulted in successful 
consolidation in all cases.79 Finally, in iliac crest defects treated with Biocoral®, a poor bone ingrowth 
was observed only in biopsies at one year of follow-up.80   
 
Discussion and Future directions 
 
 
An ideal bone graft substitute should be osteoconductive, inert, readily available and adaptable 
in terms of size and shape. It should also be biodegradable, to allow bone ingrowth and provide 
structural support. Corals pose several of the aforementioned properties. Coral structure is similar to 
cancellous bone and one of the few xenogeneic materials that can form chemical bonds with bone in-
vivo. Coral based biomaterial could overcome the drawbacks of autologous bone grafting.  
Coralline calcium carbonate based materials were considered to have a high-resolution rate, poor 
longevity and stability. They rely on bone ingrowth for structural support and predominately they were 
used to fill well-contained voids. The available literature utilizing calcium carbonate grafts for fracture 
healing is rather limited. Their resorption is unpredictable with some authors reporting full resorption 
while in other studies the resorption was poor. In cases of scaphoid fracture non-union, treated with 
composites of calcium carbonate coral, collagen and bone morphogenetic protein, poor results have 
been documented.78 The authors stated that in such avascular conditions the coral did not resorb 
adequately and acted as a barrier between the two bone parts obstructing the healing process. In a later 
study by the same group, complete union was achieved utilizing the same composite graft in 5 ulnar 
non-unions.79 
To overcome the weaknesses of calcium carbonate, conversion of the calcium carbonate to 
hydroxyapatite has been performed. This procedure preserves the porous structure of the corals and in 
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theory delays the resorption of the graft. Unfortunately, this new material is either slowly resorbed or 
considered by some as permanent.  In animal models, White et al. highlighted that the resorption rate 
varies between 0 to 5% per year.56 Several authors have also raised concerns in terms of the slow 
resorption of coralline hydroxyapatite.62 Coughlin et al. analysed the clinical outcome of 10 patients 
treated with hindfoot arthrodesis with the application of Pro Osteon 500.62 The authors reported a 
case of nonunion but satisfactory results in the remaining patients, and highlighted the difficulties to 
contain the graft material with asymptomatic extrusion of the graft in all the cases. They also raised 
concerns regarding the slow resorption rates and the presence of the graft material 6 years following 
implantation. 
The permanent nature of the coralline hydroxyapatite has triggered the development of a 
µUHVRUEDEOH¶YHUVLRQRIWKHimplant. For the fabrication of this implant the same replamineform process 
was utilized, however, only partial with conversion.90 The new implant is composed of coralline 
hydroxyapatite limited to 2 to 10 microns on the outer surface and has an unconverted inner core which 
remains as calcium carbonate.90 The aim theoretically is a more resorbable implant but also represents 
a concern as this is an unpredictable factor in terms of the graft properties and overall function in-vivo. 
The available literature is limited and the full potential of this construct is yet to be elucidated.  
Coralline graft substitutes have several other disadvantages. Their effectiveness seems to be 
influenced by the anatomic site of implantation. As mentioned before in areas of poor blood supply they 
seem to produce poor results. The anatomic location also seems to influence the results possibly related 
to the overall local vascularity.  
Another major disadvantage of the coral material is the initial mechanical weakness. Once bone 
in-growth occurs the mechanical stability improves. It is characteristic that the compressive strength of 
corals could be as low as 2.62MPa when the one of bone is between 131 and 283 MPa.13 In this context, 
FDA has issued warnings for one of the commercially available corals.91 Briefly the Pro Osteon use 
is contraindicated in segmental defects, fracture of the growth plate, in patients with systemic or 
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metabolic disorders affecting bone healing, in vascularly impaired bone, in infected sites or in cases 
when soft tissue coverage is not possible and finally cases where stabilization of the fracture cannot be 
attained. 91 In addition, FDA database clearly indicates that Pro 2VWHRQ does not pose sufficient 
mechanical strength to support fracture reduction and relies on bone ingrowth to stabilize the defect 
site. 91 
Even if the above-mentioned issues are addressed, corals can be considered a viable solution as 
a bone graft material only if they are sustainable and with minimal environmental impact.92 Porities and 
Goniopora corals that are used for the commercially available products derive from corals of the Pacific 
and Indian Oceans. These corals are not classed as endangered, however, their overexploitation together 
with the environmental changes, ocean warming and acidification could put them at risk. Furthermore, 
some authors highlighted the negative effect or even complete cessation of the overall calcification that 
the rising water temperature and acidity has on these corals.13,93,94 In addition, a substantial decrease in 
the coral reefs has been noted since 1990 and it is expected that approximately 50% of the reefs will be 
destroyed by 2030.13 These data add to the overall uncertainty when planning to explore the utilization 
of the corals further.  
Despite all the aforementioned concerns, we believe that some coral derived biomaterials are 
good void fillers with distinct role in our armamentarium. Their utilization should be performed with 
prior knowledge of the properties of each different product. The fact that they are inner osteoconductive 
material, safe from a disease transmission point of view, and also the need to incorporate an 
osteoinductive signal to safeguard the overall success, is an undisputable strength. As far as the coralline 
hydroxyapatite is concerned, this should be considered as a permanent implant, the effectiveness of the 
partially converted analogue would require further investigation in terms of their overall effectiveness 
and properties in clinical applications. Tissue engineering approaches with graft supplementation with 
different osteogenic cells, bone marrow, platelet rich plasma and a number of growth factors is 
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promising but the ideal combination enhancing the neoangiogenesis and osteogenesis needs further 
clarification.         
 
Conclusions 
 
Research is ongoing on strategies how to enhance and optimize bone repair strategies.95-100 
Ongoing research Coralline-derived bone grafts are safe, inert osteoconductive material, which are 
readily available in nature. Their highly porous structure is similar to cancellous bone. Raw coralline 
graft products are brittle, lack mechanical strength and are resorbed by the host fast. The conversion to 
hydroxyapatite diminishes the resorption of the graft making it a permanent implant. Our current clinical 
evidence is limited to well-contained voids in dental and maxillofacial surgery. Some authors report 
good clinical results, yet others reported devastating poor outcomes. Until further clarification and 
development of new coral based implants that address the short-comings of the current materials the 
utilization of such material should be limited to well contained, well vascularized defects, bearing into 
consideration the potential permanent nature of the this graft material. 
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Table 1. Clinical studies analyzing the RXWFRPHRI3UR2VWHRQLQSDWLHQWV 
Study/ Year Participants Condition site Study characteristics Outcome 
Krejci et al., 1987 
56
 
12 pts Periondontal  angul
ar osseous defects 
Each patient had 3 
defects, one filled with 
Pro Osteon 200, one 
with OrthoMatrix HA-
500 and one unfilled 
x While the defect sites improved 
with respect to plaque index, 
probing depth measurements, and 
defect fill, only those treated with 
the nonporous OrthoMatrix HA-
500 hydroxyapatite revealed a 
statistically significant 
improvement treatment 
modalities.  
Bucholz et al., 
1989 63 
49 pts Closed Tibial 
plateau fractures 
RCT, 20 pts treated with 
Pro-Osteon, 20 patients 
with autograft from Iliac 
crest, 9 lost in FU 
x No significant differences in the 
two groups 
x Interporous hydroxyapatite is a 
safe, effective alternative to 
autogenous cancellous bone for 
the filling of metaphyseal defects 
associated with Tibial plateau 
fractures. 
Salyer et al., 1989 
70
 
25 pts Maxillofacial 
deformities 
Non-randomised, 17 pts 
treated with Pro Osteon 
200, 8 pts with 
autograft 
x No difference in length of stay, 
clinical function, complications 
and aesthetic performance 
Oreamuno et al., 
1990 57 
24 pts Periondontal  angul
ar osseous defects 
The defects were 
randomly filled with 
either Pro Osteon or 
decalcified freeze-dried 
bone  
x Pro Osteon produced greater 
reduction in pocket depth and 
higher attachment levels and 
defect fill 
Hjorting-Hansen 
et al., 1990 59 
22 pts Periondontal 
osseous defects 
Bone biopsies and 
histologic examination of 
Interpore 200 
x New bone formation was notes 
within the grafts.  
Small et al., 1993 
60
 
27 pts Maxillary sinus 
augmentation 
Graft material composed 
of Interpore 200 and 
demineralized cortical 
bone 
x Integration noted in all implants 
 
Byrd et al., 1993 61 43 pts Craniofacial bone 
augmentation 
52 sites in 43 patients for 
the aesthetic correction of 
congenital or 
posttraumatic deformities 
x Resorption not occurred, no cases 
of infection, 2 patients required 
revision 
Nicolaides et al., 
2000 72 
2 pts Open 
supracondylar 
osteotomies 
Treatment of valgus 
deformities using coral 
wedge 
x No complications with complete 
incorporation of the graft 
Irwin et al. 2001 71 71 pts Bone defects 
derived from 
excision of tumours 
Retrospective review of 
consecutive patients 
managed with coralline 
hydroxyapatite Pro-
Osteon 500  
x Complications encountered in 12 
patients (3 major and 9 minor 
complications) 
x Pro-Osteon 500 is a viable 
option for the management 
of bone defects in orthopaedic 
oncology. 
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Thalgott et al., 
2001 65 
40 pts Lumbar fusion Retrospective series of 
40 patients undergoing 
instrumented autogenous 
posterolateral lumbar 
fusion augmented with 
Pro Osteon 500  
x An overall fusion rate of 92.5% 
was achieved 
x Coralline hydroxyapatite is an 
effective bone graft extender in 
difficult-to-fuse patients 
Thalgott et al., 
1999 69 
26 pts Cervical fusion Retrospective, 26 patients 
anterior discectomy and 
reconstruction from C3 to 
T1 
x No evidence of plate breakage, 
screw breakage, resorption of the 
implant, or pseudarthrosis.  
x There was no evidence of 
nonunion. 
Mashoof et al., 
2002 64 
27 pts Adolescent 
idiopathic scoliosis 
Consecutive patients, 
70/30 ratio of coralline 
hydroxyapatite to 
autograft  
x All patients achieved solid fusion 
at an average follow-up of 27 
months.  
x Coralline hydroxyapatite is safe, 
biocompatible, and effective in 
augmenting 
autogenous bone graft 
Korovessis et al., 
2002 66 
13pt Cervical, thoracic, 
lumbar spine fusion 
Biopsies during revision 
surgery 
x Foreign-body like giant cells & 
development of inflammatory 
granulation tissue around 
hydroxyapatite 
x Bone formation was observed in 
11/15 cases 
Korovessis et al., 
2005 67 
60 Lumbar spine 
fusion 
Prospective randomized 
study, 3 Groups: Pro 
Osteon 500 R vs Iliac 
Crest graft vs both 
x No radiological evidence of non-
union 
x The resorption of hydroxyapatite 
was completed 1 year 
postoperatively.  
Coughlin et al., 
2006 62 
10 Hindfoot 
arthrodesis 
Retrospective review, 6 
years FU  
x One case of non-union 
x Extrusion of the graft from the 
joint occurred in all patients  
Wasielewski et al. 
2008 71 
17 pts Complex 
acetabular 
reconstruction 
 
Retrospective review of 
patients who underwent 
acetabular revision 
using Pro Osteon 500  
x No cups required re-revision, but 1 
had failed.  
x Radiographic evidence of bone 
incorporation was observed in 
every coralline hydroxyapatite 
graft.  
x No graft resorption was observed. 
RCT: Randomised Controlled Study, FU: Follow-up, Pts: Patients 
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Table 2. Clinical studies analyzing the outcome of Biocoral® in patients. 
Study/ Year Participants Condition site Study characteristics Outcome 
Marchac et al., 1994 11 36 pts Craniofacial osseous 
contour defects 
36 consecutive patients 
requiring correction of 54 minor 
bony contour defects 
x 5 sites of clinically evident resorption 
x 2 incidences of wound irritation  
x 1 case of infection 
Roux et al., 1995 74 183 pts Cranial base 
reconstruction 
587 Madreporic Coral grafts as 
bone substitute 
x In 20% of cases the coral block moved or 
was partly resorbed and split into pieces 
after 7 to 36 months 
x 40 to 50% resorption of their volume after 
a year or more 
x The local infection rate was only 4% 
Piattelli et al., 1996 82 6 pts Deficient alveolar 
ridges 
Biocoral® gel particles in 
connection with expanded 
polytetrafluoroethylene 
membranes 
x At 6 months Biocoral® particles were still 
present and almost all were completely 
surrounded by mature bone 
Yukna et al., 199875 21 pts Dento-alverolar defects 48 augmentation sites 
(Biocoral® or bone graft ) 
x 2 implants failed to osseo-integrate 
x One case of infection with resorption of 
coral granules was observed in the 
anterior maxilla. 
x When Biocoral® placed in anterior maxilla 
a high revision rate was observed (83% 
revision rate) in contrast to posterior 
maxilla and mandible (6% revision rate) 
Bizette et al., 1999 76 48 pts Cervical fusion Retrospective review of cases x Clinical improvement in 52% of pts 
x Fusion rate 60% 
Vuola et al., 2000 80 10 pts Iliac crest defects Biopsies performed at 1 year x All the blocks still detectable at 2.1 years.  
x Bone ingrowth could be observed only in 
two out of seven biopsies.  
x One implant had to be removed after 1.7 
years due to infection. 
Kujula et al., 2002 78 10 Scaphoid fractures BMP/coral/collagen composite 
implant 
x 80% failure of union 
Kujala et al., 2004 79 5 pts 4 Diaphyseal and one 
olecranon ulnar non-
unions 
BMP/coral implant combined 
with internal fixation. 
Additional autografting was 
used in three cases. 
x Solid union was achieved in all cases.  
x No adverse effects were encountered. 
Scarano et al., 2006 81 94 pts Maxillary sinus 
Augmentation 
Histological examination of 
biopsy performed 6 months 
after implantation. 
x No inflammatory cell infiltrate was 
present 
x Graft particles appeared to be fused by 
newly formed bone 
x Areas of resorption were present at the 
surface of some graft particles 
Ramzi et al., 2008 76 40 pts Cervical fusion Prospective study, Anterior 
cervical fusion 
x 45% fusion rate at 44 months (22 out of 40 
patients not fused) 
RCT: Randomised Controlled Study, FU: Follow-up, Pts: Patients 
 
 
 
